News & Updates

Show Multimedia Only
Methylnaltrexone proves safety in paediatric oncology patients with constipation

Methylnaltrexone proves safety in paediatric oncology patients with constipation

24 Feb 2024

Subcutaneous methylnaltrexone is safe to use in children with cancer who have opioid-induced constipation, suggest the results of a study. In addition, this agent stimulates bowel movements in more than a third of paediatric patients.

24 Feb 2024
Children of mothers with AD prone to develop AD, other allergic illness Children of mothers with AD prone to develop AD, other allergic illness

Children of mothers with AD prone to develop AD, other allergic illness

22 Feb 2024

Children whose mothers have atopic dermatitis (AD) are likely to develop the same disease, while some develop other allergic illness (OAI) first, reports a study. This suggests that not everyone will follow the same sequential pathway.

22 Feb 2024